DRP Journal

FDA Approves Boston Scientific’s (NYSE:BSX ) Ranger™ DCB In Peripheral Artery Disease

Boston Scientific (NYSE:BSX) has announced that the US FDA has approved the Ranger™ Drug-Coated Balloon. It is under development to